These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7843855)

  • 1. OHM3295: a fentanyl-related 4-heteroanilido piperidine with analgesic effects but not suppressive effects on splenic NK activity in mice.
    Carr DJ; Baker ML; Holmes C; Brockunier LL; Bagley JR; France CP
    Int J Immunopharmacol; 1994 Oct; 16(10):835-44. PubMed ID: 7843855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fentanyl-related 4-heteroanilido piperidine OHM3295 augments splenic natural killer activity and induces analgesia through opioid receptor pathways.
    Baker ML; Brockunier LL; Bagley JR; France CP; Carr DJ
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1285-92. PubMed ID: 7562500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone antagonizes the analgesic and immunosuppressive effects of morphine in mice.
    Carr DJ; Gerak LR; France CP
    J Pharmacol Exp Ther; 1994 May; 269(2):693-8. PubMed ID: 8182537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirfentanil antagonizes morphine-induced suppression of splenic NK activity in mice.
    Carr DJ; Brockunier LL; Scott M; Bagley JR; France CP
    Immunopharmacology; 1996 Aug; 34(1):9-16. PubMed ID: 8880221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of natural killer cell activity by high-dose narcotic anesthesia in rats.
    Beilin B; Martin FC; Shavit Y; Gale RP; Liebeskind JC
    Brain Behav Immun; 1989 Jun; 3(2):129-37. PubMed ID: 2477090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rate-decreasing effects of fentanyl derivatives in pigeons before, during and after chronic morphine treatment.
    Gauthier CA; Gerak LR; Bagley JR; Brockunier LL; France CP
    Psychopharmacology (Berl); 1998 May; 137(1):67-73. PubMed ID: 9631958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys.
    France CP; Gerak LR; Flynn D; Winger GD; Medzihradsky F; Bagley JR; Brockunier LL; Woods JH
    J Pharmacol Exp Ther; 1995 Jul; 274(1):17-28. PubMed ID: 7616395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects.
    France CP; Winger G; Medzihradsky F; Seggel MR; Rice KC; Woods JH
    J Pharmacol Exp Ther; 1991 Aug; 258(2):502-10. PubMed ID: 1650830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narcotic-induced suppression of natural killer cell activity in ventilated and nonventilated rats.
    Beilin B; Shavit Y; Cohn S; Kedar E
    Clin Immunol Immunopathol; 1992 Aug; 64(2):173-6. PubMed ID: 1643747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of receptor mechanism mediating fentanyl analgesia and toxicity.
    Jang Y; Yoburn BC
    Eur J Pharmacol; 1991 May; 197(2-3):135-41. PubMed ID: 1655470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of a potent, efficacious fentanyl derivative in rhesus monkeys.
    France CP; Winger G; Seggel MR; Rice KC; Woods JH
    Psychopharmacology (Berl); 1992; 109(3):291-8. PubMed ID: 1365629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study.
    Shavit Y; Ben-Eliyahu S; Zeidel A; Beilin B
    Neuroimmunomodulation; 2004; 11(4):255-60. PubMed ID: 15249732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress-induced modulation of NK activity during influenza viral infection: role of glucocorticoids and opioids.
    Tseng RJ; Padgett DA; Dhabhar FS; Engler H; Sheridan JF
    Brain Behav Immun; 2005 Mar; 19(2):153-64. PubMed ID: 15664788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of endogenous and exogenous opioids on splenic natural killer cell activity.
    Kraut RP; Greenberg AH
    Nat Immun Cell Growth Regul; 1986; 5(1):28-40. PubMed ID: 3010087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity.
    Freier DO; Fuchs BA
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1127-33. PubMed ID: 7932161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity.
    Shavit Y; Martin FC; Yirmiya R; Ben-Eliyahu S; Terman GW; Weiner H; Gale RP; Liebeskind JC
    Brain Behav Immun; 1987 Dec; 1(4):318-28. PubMed ID: 3453207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
    Comer SD; Burke TF; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1051-6. PubMed ID: 1326622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the analgesic properties of fentanyl-like opioids with alpha 2-adrenoceptor agonists in rats.
    Meert TF; De Kock M
    Anesthesiology; 1994 Sep; 81(3):677-88. PubMed ID: 7916547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
    Adams JU; Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1027-32. PubMed ID: 2175793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central alpha-adrenergic involvement in morphine-mediated suppression of splenic natural killer activity.
    Carr DJ; Mayo S; Gebhardt BM; Porter J
    J Neuroimmunol; 1994 Aug; 53(1):53-63. PubMed ID: 8051298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.